Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Peapack Gladstone Financial Corp

Peapack Gladstone Financial Corp decreased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 5.6% in the 3rd quarter, Holdings Channel.com reports. The fund owned 881 shares of the biotechnology company’s stock after selling 52 shares during the period. Peapack Gladstone Financial Corp’s holdings in Axon Enterprise were worth $352,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in AXON. Quent Capital LLC boosted its holdings in Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after purchasing an additional 75 shares during the period. Prestige Wealth Management Group LLC lifted its position in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after buying an additional 79 shares during the period. Brooklyn Investment Group acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at about $41,000. Finally, Planning Capital Management Corp raised its stake in Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the sale, the director now directly owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. This represents a 3.96 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the transaction, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 99,590 shares of company stock worth $49,435,607 over the last ninety days. Company insiders own 6.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on AXON. Needham & Company LLC lifted their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Robert W. Baird raised their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Finally, JMP Securities increased their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $488.67.

Axon Enterprise Trading Up 0.7 %

Shares of NASDAQ:AXON opened at $649.30 on Tuesday. Axon Enterprise, Inc. has a twelve month low of $241.72 and a twelve month high of $698.67. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a market cap of $49.51 billion, a P/E ratio of 167.78, a P/E/G ratio of 14.19 and a beta of 1.01. The company has a 50 day moving average of $544.09 and a 200-day moving average of $408.89.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.